The interactions of prostaglandins with the sympathetic nervous system--a review
- PMID: 6308093
- DOI: 10.1016/0165-1838(83)90017-6
The interactions of prostaglandins with the sympathetic nervous system--a review
Abstract
In most isolated tissues, prostaglandins, particularly of the E-series, inhibit stimulated norepinephrine release from prejunctional nerve endings and inhibit sympathetic neurotransmission. They may also modulate the response of target organs to the neurotransmitter. In some tissues PGE enhances the response to norepinephrine. It appears that the effect of PGE on norepinephrine release is mediated by restriction of calcium availability at the nerve ending, although this mechanism is incompletely understood. Prostaglandins other than PGE do not appear to play a major role in the modulation of norepinephrine release. In the intact organism, prostaglandins facilitate norepinephrine release. Inhibition of prostaglandin synthesis causes a decrease in norepinephrine release. It is not clear if the effects in vivo are mediated by a direct action of prostaglandins or through baroreceptor reflex mechanisms.
Similar articles
-
Prostaglandin actions on the adrenergic nervous system.Klin Wochenschr. 1983 Jun 1;61(11):533-40. doi: 10.1007/BF01486842. Klin Wochenschr. 1983. PMID: 6308336 No abstract available.
-
Role of endogenous prostaglandins in regulation of uterine blood flow and adrenergic neurotransmission.Am J Obstet Gynecol. 1977 Mar 1;127(5):455-61. doi: 10.1016/0002-9378(77)90434-3. Am J Obstet Gynecol. 1977. PMID: 189613
-
Muscarinic and beta-adrenergic prejunctional modulation of adrenergic neurotransmission in the blood vessel wall.Gen Pharmacol. 1983;14(1):35-7. doi: 10.1016/0306-3623(83)90059-9. Gen Pharmacol. 1983. PMID: 6298057 Review.
-
Regulation mechanisms of central and peripheral sympathetic neurons.J Neural Transm. 1975;Suppl 12:115-26. doi: 10.1007/978-3-7091-8384-7_6. J Neural Transm. 1975. PMID: 169320 No abstract available.
-
Prostaglandins and the release of the adrenergic transmitter.Ann N Y Acad Sci. 1990;604:222-36. doi: 10.1111/j.1749-6632.1990.tb31996.x. Ann N Y Acad Sci. 1990. PMID: 1977349 Review.
Cited by
-
Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266.Naunyn Schmiedebergs Arch Pharmacol. 2010 Jan;381(1):21-31. doi: 10.1007/s00210-009-0478-9. Epub 2009 Dec 10. Naunyn Schmiedebergs Arch Pharmacol. 2010. PMID: 20012265
-
Role of mucosal prostaglandins in vagally-mediated adaptive cytoprotection in the rat.Gastroenterol Jpn. 1992 Feb;27(1):1-8. doi: 10.1007/BF02775057. Gastroenterol Jpn. 1992. PMID: 1555738
-
Associations of Prior Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Glucocorticoids With Cachexia Incidence and Survival.Front Oncol. 2022 Jun 7;12:922418. doi: 10.3389/fonc.2022.922418. eCollection 2022. Front Oncol. 2022. PMID: 35747801 Free PMC article.
-
Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs.Drugs. 1988 Oct;36(4):475-90. doi: 10.2165/00003495-198836040-00005. Drugs. 1988. PMID: 3069437 Review.
-
Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis.Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):156-65. doi: 10.1007/BF00505816. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3024031
MeSH terms
Substances
LinkOut - more resources
Full Text Sources